BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37068532)

  • 1. Development of carbon monoxide-releasing molecules conjugated to polysaccharides (glyco-CORMs) for delivering CO during obesity.
    Mohan S; Barel LA; Benrahla DE; Do B; Mao Q; Kitagishi H; Rivard M; Motterlini R; Foresti R
    Pharmacol Res; 2023 May; 191():106770. PubMed ID: 37068532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon monoxide-induced metabolic switch in adipocytes improves insulin resistance in obese mice.
    Braud L; Pini M; Muchova L; Manin S; Kitagishi H; Sawaki D; Czibik G; Ternacle J; Derumeaux G; Foresti R; Motterlini R
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
    Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
    Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
    Nobre LS; Jeremias H; Romão CC; Saraiva LM
    Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
    Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
    Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
    Lazarus LS; Benninghoff AD; Berreau LM
    Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances on Carbon Monoxide Releasing Molecules for Antibacterial Applications.
    Cheng J; Hu J
    ChemMedChem; 2021 Dec; 16(24):3628-3634. PubMed ID: 34613654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs).
    Khan H; Faizan M; Niazi SUK; Madiha ; Muhammad N; Zhang W
    Top Curr Chem (Cham); 2022 Dec; 381(1):3. PubMed ID: 36515756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
    Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
    Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet.
    Hosick PA; AlAmodi AA; Storm MV; Gousset MU; Pruett BE; Gray W; Stout J; Stec DE
    Int J Obes (Lond); 2014 Jan; 38(1):132-9. PubMed ID: 23689359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs.
    Pak O; Bakr AG; Gierhardt M; Albus J; Strielkov I; Kroschel F; Hoeres T; Hecker M; Ghofrani HA; Seeger W; Weissmann N; Sommer N
    J Appl Physiol (1985); 2016 Jan; 120(2):271-81. PubMed ID: 26586910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
    Chatterjee PK
    Br J Pharmacol; 2004 Jun; 142(3):391-3. PubMed ID: 15148242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
    Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
    Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
    Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
    Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs).
    Choi HI; Zeb A; Kim MS; Rana I; Khan N; Qureshi OS; Lim CW; Park JS; Gao Z; Maeng HJ; Kim JK
    J Control Release; 2022 Oct; 350():652-667. PubMed ID: 36063960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration.
    Jesse HE; Nye TL; McLean S; Green J; Mann BE; Poole RK
    Biochim Biophys Acta; 2013 Sep; 1834(9):1693-703. PubMed ID: 23624261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
    Bauer N; Yuan Z; Yang X; Wang B
    Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
    Sawle P; Foresti R; Mann BE; Johnson TR; Green CJ; Motterlini R
    Br J Pharmacol; 2005 Jul; 145(6):800-10. PubMed ID: 15880142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.